Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7442
Gene Symbol: TRPV1
TRPV1
0.310 Biomarker phenotype CTD_human Influence of intra-oesophageal capsaicin instillation on heartburn induction and oesophageal sensitivity in man. 19566590 2009
Entrez Id: 7442
Gene Symbol: TRPV1
TRPV1
0.310 AlteredExpression phenotype BEFREE Under these conditions, the TRPV1 can be activated by a slight increase in airway temperature or tissue acidity. 17346945 2007
Entrez Id: 1557
Gene Symbol: CYP2C19
CYP2C19
0.040 GeneticVariation phenotype BEFREE It is also crucial to determine the reason of the eradication failure, including host-related factors (poor compliance to eradication regimen, smoking, and cytochrome P450 2C19 genetic polymorphism) or treatment-related factors (inadequate dosage or duration of therapy and gastric acidity), as such factors can be modified for a tailored therapy.Although the indications for <i>H. pylori</i> eradication have widened, patients at a high risk of gastric cancer can gain definitive benefits with a 3rd-line or even 4th-line therapy. 29853863 2018
Entrez Id: 1557
Gene Symbol: CYP2C19
CYP2C19
0.040 GeneticVariation phenotype BEFREE In erosive esophagitis patients, the FSSG scores of the CYP2C19 rapid metabolizers (RMs) were significantly higher than the scores of the poor metabolizers and intermediate metabolizers (total scores: 16.7 ± 8.6 <i>vs</i> 7.8 ± 5.4, <i>P</i> < 0.05; acid reflux-related symptom scores: 12 ± 1.9 <i>vs</i> 2.5 ± 0.8, <i>P</i> < 0.005). 28373773 2017
Entrez Id: 1557
Gene Symbol: CYP2C19
CYP2C19
0.040 GeneticVariation phenotype BEFREE To compare the effect of generic omeprazole 20 mg/day with esomeprazole 20 mg/day on intragastric acidity and to investigate the influence of the CYP2C19 metabolizer status. 21175704 2011
Entrez Id: 1557
Gene Symbol: CYP2C19
CYP2C19
0.040 Biomarker phenotype BEFREE H. pylori status had less influence than CYP2C19 on intragastric acidity. 10982760 2000
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.030 Biomarker phenotype BEFREE The risk of upper gastrointestinal complications (including dyspepsia, gastritis and heartburn) was significantly increased with COX-2 inhibitors versus placebo (RR 1.19, 95% CI 1.03-1.38; I<sup>2</sup> = 0%), particularly for abdominal pain, which increased by 40% with COX-2 inhibitors (RR 1.40, 95% CI 1.08-1.80; I<sup>2</sup> = 0%). 31073922 2019
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.030 AlteredExpression phenotype BEFREE The protective effect was associated with decreased lipid peroxidation, increased prostaglandin E<sub>2</sub>, reduction in gastric acidity and reduction in COX-2 mRNA expression which was altered by stress. 30697274 2019
Entrez Id: 1540
Gene Symbol: CYLD
CYLD
0.030 GeneticVariation phenotype BEFREE Acidity in the TEM drives MnO<sub>2</sub> to generate ROS, ∙OH among which further triggers the decomposition of FeCO into CO, realizing the effective combination of CDT and CDGT. 31196217 2019
Entrez Id: 100188881
Gene Symbol: MFT2
MFT2
0.030 GeneticVariation phenotype BEFREE Acidity in the TEM drives MnO<sub>2</sub> to generate ROS, ∙OH among which further triggers the decomposition of FeCO into CO, realizing the effective combination of CDT and CDGT. 31196217 2019
Entrez Id: 64102
Gene Symbol: TNMD
TNMD
0.030 GeneticVariation phenotype BEFREE Acidity in the TEM drives MnO<sub>2</sub> to generate ROS, ∙OH among which further triggers the decomposition of FeCO into CO, realizing the effective combination of CDT and CDGT. 31196217 2019
Entrez Id: 100188881
Gene Symbol: MFT2
MFT2
0.030 Biomarker phenotype BEFREE SEM, TEM, and CLSM analysis revealed that the coacervation acidity influenced the swelling and BSA release behavior by changing the matrix density and O-CMC content of the coacervates. 28629036 2017
Entrez Id: 100188881
Gene Symbol: MFT2
MFT2
0.030 Biomarker phenotype BEFREE Degradation of each particle was studied by using ICP, TEM, and gas sorption measurement and analyzed in terms of structural parameters, external particle surface dissolution, and acidity of the PBS. 28478674 2017
Entrez Id: 64102
Gene Symbol: TNMD
TNMD
0.030 Biomarker phenotype BEFREE SEM, TEM, and CLSM analysis revealed that the coacervation acidity influenced the swelling and BSA release behavior by changing the matrix density and O-CMC content of the coacervates. 28629036 2017
Entrez Id: 1540
Gene Symbol: CYLD
CYLD
0.030 Biomarker phenotype BEFREE Degradation of each particle was studied by using ICP, TEM, and gas sorption measurement and analyzed in terms of structural parameters, external particle surface dissolution, and acidity of the PBS. 28478674 2017
Entrez Id: 1540
Gene Symbol: CYLD
CYLD
0.030 Biomarker phenotype BEFREE SEM, TEM, and CLSM analysis revealed that the coacervation acidity influenced the swelling and BSA release behavior by changing the matrix density and O-CMC content of the coacervates. 28629036 2017
Entrez Id: 64102
Gene Symbol: TNMD
TNMD
0.030 Biomarker phenotype BEFREE Degradation of each particle was studied by using ICP, TEM, and gas sorption measurement and analyzed in terms of structural parameters, external particle surface dissolution, and acidity of the PBS. 28478674 2017
Entrez Id: 768
Gene Symbol: CA9
CA9
0.030 Biomarker phenotype BEFREE In this study, we investigated the hypothesis that impeding the reuptake of bicarbonate produced extracellularly by CA9 could exacerbate the intracellular acidity produced by hypoxic conditions, perhaps compromising cell growth and viability as a result. 27197160 2016
Entrez Id: 768
Gene Symbol: CA9
CA9
0.030 AlteredExpression phenotype BEFREE We found that acidity inhibits CAIX activity over the pH range found in tumors (pK = 6.84), and this may be the mechanism whereby excess acid self-limits the build-up of extracellular acid. 22498007 2012
Entrez Id: 768
Gene Symbol: CA9
CA9
0.030 AlteredExpression phenotype BEFREE With no CA9 expression, spheroids developed very low pH(i) (approximately 6.3) and reduced pH(e) (approximately 6.9) at their core, associated with a diminishing gradient of acidity extending out to the periphery. 19458084 2009
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.030 Biomarker phenotype BEFREE Moreover, the induction of COX-2 by chenodeoxycholate was enhanced by acidity in a dose-dependent manner, and the promoter activity of COX-2 was increased by chenodeoxycholate in SNU-1041, a human laryngeal cancer cell line, whereas the transcription of COX-2 was inhibited by actinomycin-D. 12782823 2003
Entrez Id: 59330
Gene Symbol: GER
GER
0.020 Biomarker phenotype BEFREE Acid reflux is common in patients with diabetes.GER is associated with the existence of obesity rather than hyperglycemia. 30458553 2020
Entrez Id: 51305
Gene Symbol: KCNK9
KCNK9
0.020 GeneticVariation phenotype BEFREE Birk Barel syndrome also known as KCNK9 imprinting syndrome is a rare developmental disorder associated with a loss-of-function variant in KCNK9, an imprinted gene with maternal expression on the 8th chromosome encoding the TASK3 (TWIK-related acidity inhibited K + -channel 3). 30690205 2020
Entrez Id: 59330
Gene Symbol: GER
GER
0.020 Biomarker phenotype BEFREE <b>Methods:</b> Thirty-seven patients with GER-associated cough suspected based on characteristic symptoms such as heartburn and worsening of cough by phonation and rising were recruited. 31303089 2019
Entrez Id: 495
Gene Symbol: ATP4A
ATP4A
0.020 Biomarker phenotype BEFREE Heartburn that persists despite proton-pump inhibitor (PPI) treatment is a frequent clinical problem with multiple potential causes. 31618539 2019